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The conversion of L-alanine (L-Ala) into D-alanine (D-Ala) in bacteria is performed by 
pyridoxal phosphate-dependent enzymes called alanine racemases. D-Ala is an essential 20 
component of the bacterial peptidoglycan and hence required for survival. The Gram-positive 
bacterium Streptomyces coelicolor has at least one alanine racemase encoded by alr. Here, 
we describe an alr deletion mutant of S. coelicolor which depends on D-Ala for growth and 
shows increased sensitivity to the antibiotic D-cycloserine (DCS). The crystal structure of the 
alanine racemase (Alr) was solved with and without the inhibitors DCS or propionate. The 25 
crystal structures revealed that Alr is a homodimer with residues from both monomers 
contributing to the active site. The dimeric state of the enzyme in solution was confirmed by 
gel filtration chromatography, with and without L-Ala or D-cycloserine. Specificity of the 
enzyme was 66 +/- 3 U mg-1 for the racemization of L- to D-Ala, and 104 +/- 7 U mg-1 for the 
opposite direction. Comparison of Alr from S. coelicolor with orthologous enzymes from other 30 
bacteria, including the closely related D-cycloserine-resistant Alr from S. lavendulae, strongly 
suggests that structural features such as the hinge angle or the surface area between the 
monomers do not contribute to D-cycloserine resistance, and the molecular basis for 
resistance therefore remains elusive. 
 35 
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All canonical, proteinogenic amino acids, with the exception of glycine, have a stereocenter 40 
at the Cα and can exist either as the L- or D-enantiomer. While in the past it was generally 
accepted that only L-amino acids had a role in living organisms, studies revealed a variety of 
roles for free D-amino acids, for example in the regulation of bacterial spore germination and 
peptidoglycan structure [1]. Peptidoglycan is essential for cell shape and osmotic regulation 
and its biosynthesis is dependent on the availability of the less naturally abundant D-alanine 45 
[2-4]. D-alanine (D-Ala) is generated through racemization of the abundant L-enantiomer (L-
Ala) by the enzyme alanine racemase [5]. 
Alanine racemases (Alr; E.C. 5.1.1.1) are conserved bacterial enzymes that belong to the 
Fold Type III of pyridoxal phosphate (PLP)-dependent enzymes. Crystallographic studies of 
Alr’s from different bacterial species revealed a shared, conserved fold consisting of an eight-50 
stranded α/β barrel at the N-terminal domain and a second, C-terminal domain mainly 
consisting of β-sheets. The PLP cofactor is bound to a very conserved lysine residue at the 
N-terminal side of the last helix of the barrel. In all studies, Alr’s crystals consist of homo-
dimers, with residues from both monomers participating in the formation of the active site. 
Nevertheless, in-solution studies indicated an equilibrium between monomeric and homo-55 
dimeric states in solution, with the homo-dimer being the catalytically active form [6, 7]. 
Streptomyces coelicolor is the most widely studied member of the Streptomycetes, which are 
Gram-positive bacteria with a multicellular mycelial life style that reproduce via sporulation 
[8]. They are of great importance for medicine and biotechnology, accounting for over half of 
all antibiotics, as well as for many anticancer agents and immunosuppressants available on 60 
the market [9, 10]. Here we describe the heterologous expression, purification and crystal 
structure of S. coelicolor Alr, encoded by alr (SCO4745). An alr null mutant of S. coelicolor 
depends on exogenous D-Ala for growth. The purified enzyme catalyzed the racemization of 
L-Ala to D-Ala in vitro and was shown to be a dimer from gel filtration, both in the absence 
and presence of L-Ala or the inhibitor D-cycloserine (DCS). Furthermore, the crystal structure 65 
of the enzyme has been solved both in the absence and in the presence of the inhibitors 
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DCS and propionate. The comparison of the Alr enzymes from S. coelicolor and its close 
relative the DCS-resistant Streptomyces lavendulae [11] questions the structural role of Alr in 
DCS resistance. 
 70 
MATERIALS AND METHODS 
Bacterial strains and culturing conditions 
Escherichia coli strains JM109 [12] and ET12567 [13] were used for routine cloning 
procedures and for extracting non-methylated DNA, respectively. E. coli BL21 Star 
(DE3)pLysS was used for protein production. Cells of E. coli were incubated in lysogenic 75 
broth (LB) at 37C. Streptomyces coelicolor A3(2) M145 was obtaime from the John Innes 
cenre strin collection and was the parent of all mutants in this work. All media and routine 
Streptomyces techniques have been described in the Streptomyces laboratory manual [13]. 
Soy, flour and mannitol (SFM) agar plates were used for propagating S. coelicolor strains 
and for preparing spore suspensions. Solid minimal medium (MM) agar plates supplied with 80 
1% (w/v) mannitol was used for phenotypic characterization. The MIC for D-cycloserine was 
measured in triplicate in 96 well plates containing solid MM, D-alanine and D-cycloserine. 
Growth was assayed after two days using a resazurin-assay [14]. 
 
Streptomyces coelicolor knock-out mutant and genetic complementation 85 
S. coelicolor alr deletion mutants were constructed as previously described [15]. The -1238/-
3 and +1167/+2378 regions relative to the start of alr were amplified by PCR using primer 
alr_LF and alr_LR, and alr_RF and alr_RR (Table S2) as described [16]. The left and right 
flanks were cloned into the unstable, multi-copy vector pWHM3 (Table S1) [17], to allow for 
efficient gene disruption [18]. The apramycin resistance cassette aac(3)IV flanked by loxP 90 
sites was cloned into the engineered XbaI site to create knock-out construct pGWS1151. 
Media were supplemented with 1 mM D-Ala to allow growth of alr mutants. The correct 
recombination event in the mutant was confirmed by PCR. For genetic complementation, the 
-575/+1197 region (numbering relative to the alr translational start codon) encompassing the 
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promoter and coding region of SCO4745 was amplified from the S. coelicolor M145 95 
chromosome using primer 4745FW-575 and 4745RV+1197 (Table S2) and cloned into 
pHJL401 [19]. pHJL401 is a low-copy number shuttle vector that is very well suited for 
genetic complementation experiments [20]. 
 
Cloning, protein expression and purification 100 
The alr gene (SCO4745) was PCR-amplified from genomic DNA of Streptomyces coelicolor 
using primers alr-FW and alr-RV (Table S2), and cloned into pET-15b with a N-terminal His6 
tag. The construct was transformed into E. coli BL21 Star (DE3)pLysS electrocompetent cells 
(Novagen). E. coli cultures were incubated in LB medium at 37C until an OD600 of 0.6 and 
gene expression induced by adding 0.5 mM isopropyl β-D-1-thiogalactopyranoside (IPTG) 105 
followed by overnight incubation at 16C. His6-tagged Alr was purified using a pre-packed 
HisTrap FF column (GE Healthcare) as described [21]. Briefly, after binding of the protein, 
the column was washed with ten column volumes of 20 mM sodium phosphate buffer, pH 
7.0, 500 mM NaCl and 50 mM imidazole and N-terminally His6-tagged Alr eluted with the 
same buffer but containing 250 mM imidazole. Fractions containing the Alr were deslated 110 
using a PD-10 column (GE Healthcare) to remove the imidazole and Alr purified further by 
gel-filtration using a Superose-12 column (GE Healthcare). The collected fractions were 
analyzed by SDS-PAGE and those containing pure Alr were pooled, concentrated using a 
Centriprep centrifugal filter unit (10 kDa cut-off, Millipore), and flash-frozen in liquid nitrogen.  
 115 
Enzymatic assay for recombinant Alr 
0.2 nM purified Alr was added to 10 mM L-Ala in 20 mM PBS buffer, pH 7.0 and incubated at 
room temperature (21°C) for 0, 1, 5, 15, 30, and 60 min. The reaction was stopped by heat 
inactivation for 3 min at 95°C. As a control, 0.2 nM heat-inactivated Alr was used. A 20-µL 
aliquot of the reaction mixture was added to a 2-mL well in a 24-well plate containing solid 120 
MM, inoculated with the alr mutant. 0, 10 µM, 50 µM 100 µM, 500 µM and 1 mM D- and L-Ala 
were added as controls. 
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Mass spectrometry analysis 
The identity of the heterologous Alr was verified by mass spectrometry of the tryptic digest. 125 
Five μg of purified Alr were denatured in 50 μL 8 M urea in 100 mM NH4HCO3. The cysteine 
residues were reduced with 5 μL of 5 mM dithiothreitol (DTT) for 15 min at 50C alkylated 
with 10 μL of 10 mM iodoacetamide at room temperature in the dark for 30 min. The protein 
was digested overnight at 37C using 50 ng of modified porcine trypsin (Promega) in 350 μL 
of 20 mM NH4HCO3. The tryptic digest was desalted using stage tips [22], dried and 130 
resuspended in 50 μL of H2O:ACN:FA (96.9:3:0.1) solution. The LTQ-Orbitrap (Thermo 
Fisher Scientific, Waltham, MA) tandem mass spectrometry analysis was performed as 
previously described  [22]. 
 
Crystallization conditions and data collection 135 
Purified Alr was concentrated to 20 mg mL-1 and crystallization conditions were screened by 
sitting-drop vapor-diffusion using the JCSG+ and PACT premier (Molecular Dimensions) 
screens at 20C with 500-nL drops. The reservoir (75 μL) was pipetted by a Genesis RS200 
robot (Tecan). Drops were made by an Oryx6 robot (Douglas Instruments). After 1 day, 
crystals grew in condition number 2-38 of PACT premier, which consisted of 0.1 M BIS-TRIS 140 
propane, pH 8.5, 0.2 M NaBr, 20% (w/v) PEG3350. Bigger crystals were grown in 1-μL 
drops. Prior to flash-cooling in liquid nitrogen, crystals were soaked in a cryosolution 
consisting of mother liquor, 10% glycerol and 10, 5, or 1 mM inhibitor to obtain the DCS- and 
propionate-bound structures. 
X-ray data collection was performed at the ESRF (Grenoble, France) on beamline ID23-1 145 
[23] using a PIXEL, Pilatus_6M_F X-ray detector. A total of 1127 frames were collected for 
the native Alr, with an oscillation of 0.15, an exposure time of 0.378 s, total 426.006 s. The 
data set was processed by XDS [23] and scaled by AIMLESS [24] to a resolution of 2.8 Å. 
For the DCS-bound Alr 960 frames were collected, with an oscillation range of 0.15, an 
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exposure time of 0.071 s per image and a total time of 68.16 s. For the propionate-bound 150 
structure, 1240 images were collected, with an oscillation degree of 0.1, an exposure time 
per image of 0.037 s, and a total time of 45.88 s. Both inhibitor-bound data sets were auto-
processed by the EDNA Autoprocessing package in the mxCuBE [25] to a resolution of 
1.64 Å and 1.51 Å for the DCS-bound and propionate-bound Alr, respectively. The structures 
were solved by molecular replacement with MOLREP [26] using 1VFH as a search model 155 
from the CCP4 suite [27] and iteratively refined with REFMAC [28]. Manual model building 
was done using Coot [29]. 
 
Enzyme kinetics 
The racemization activity of Alr was determined by quantifying the derivatization product of L- 160 
and D-Ala by HPLC, as previously described [30, 31]. The derivatization reagent consisted of 
a methanol solution of 10 mg mL-1 o-phthalaldehyde (OPA, Sigma-Aldrich) and 10 mg mL-1 
Boc-L-Cys (Sigma-Aldrich). A 0.4 M boric acid solution was adjusted to pH 9.0 with sodium 
hydroxide. The reaction mixture consisted of 20 µL of 20 mM sodium phosphate buffer, pH 
7.0 containing varying amounts of L- or D-Ala from 281 µM to 20 mM. The reaction was 165 
started by adding 100 nM of enzyme and stopped after 10 min at 25C by adding 20 µL of 
2 N HCl. The reaction mixture was neutralized by NaOH. After adding 350 µL of boric acid 
buffer and 100 µL of derivatization reagent, derivatization was conducted for 5 min at 25C. 
The fluorescent products were separated on a Kinetex EVO C18 column (Phenomenex) by a 
gradient from 24% to 46.75% of acetonitrile in water in 30 min and detected by a Shimadzu 170 
RF-10AXL fluorescence detector. 
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RESULTS AND DISCUSSION 
Creation of an alr null mutant of S. coelicolor 175 
To study the role of alr in amino acid metabolism and in morphogenesis of S. coelicolor, a 
deletion mutant was created by removal of the entire coding region (see Materials & 
Methods). In line with its expected role in biosynthesis of the essential D-amino acid D-Ala, 
alr null mutants depended on exogenously added D-Ala (50 µM) for growth (Fig 1a). Re-
introducing a copy of the alr gene via plasmid pGWS1151 complemented the mutant 180 
phenotype, allowing growth in the absence of added D-Ala (Fig 1a). These data show that alr 
encodes alanine racemase in S. coelicolor, and that it most likely is the only gene encoding 
this enzyme. 
 
Alr is the only alanine racemase in S. coelicolor 185 
The Alr from S. coelicolor (AlrSco) shares 74.9% aa sequence identity with the Alr from the 
DCS-producing Streptomyces lavendulae (AlrSla) [11] and 37.9% with the well-studied Alr 
from Geobacillus stearothermophilus (AlrGst) [32] (Fig. 2). To analyze the activity and kinetics 
of the enzyme, recombinant His6-tagged Alr was expressed in E. coli BL21 Star cells and 
purified to homogenity (see Materials and Methods section). Around 45 mg of pure Alr was 190 
obtained from 1 L of bacterial culture and Alr was identified using mass spectrometry (Table 
S4).  
To establish if AlrSco converts L-Ala into D-Ala, we designed a combined in vitro and in 
vivo assay, whereby 10 mM L-Ala was incubated with 0.2 nM purified Alr-His6 for 10 sec to 
60 min, after which the enzyme was heat-inactivated and the mixture was added to minimal 195 
media (MM) agar plates, followed by plating of 106 spores of the alr null mutant and 
incubation of 5 days at 30C (Fig. 1b). If Alr converts L-Ala into D-Ala, the reaction should 
generate sufficient D-Ala to allow restoration of growth to alr null mutants. Indeed, sufficient 
D-Ala was produced to allow growth of the alr null mutant, whereby biomass accumulaiton 
was proportional to the incubation time, while a control experiment with extracts from heat-200 
inactivated Alr did not give any growth (Fig. 1b). Addition of D-Ala also restored growth of alr 
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mutants, while no growth was seen for cultures grown in the presence of added L-Ala. Taken 
together, this shows that no Alr activity is present in S. coelicolor alr mutants, and that Alr 
actively converts L-Ala into D-Ala in vitro. 
The kinetic parameters of recombinant AlrSco were determined using both L- and D-205 
Ala as substrates. The enzyme shows a Km of 6.3 mM and 8.9 mM towards L- and D-Ala, 
respectively (Table 1). For comparison, kinetic parameters of AlrSla [11] and AlrGst are also 
shown in Table 1. 
To analyze possible multimerization of AlrSco, analytical gel filtration was used, which 
established an apparent molecular weight for the protein of 83 kDa in solution both in the 210 
absence and in the presence of L-Ala and DCS (Figure S2); this corresponds roughly to two 
Alr proteins (43.4 kDa per subunit). See Supplementary Data for more details. These data 
suggest that AlrSco forms a dimer in solution, both in the presence and in the absence of 
ligands. 
 215 
Overall structure of Alr from Streptomyces coelicolor  
The crystal structure of ligand-free AlrSco was determined to a resolution of 2.8 Å (Table 2). 
The overall structure is similar to that of other prokaryotic Alr proteins [11, 33]. The 
asymmetric unit contains four protein molecules (A-D), which interact in a head-to-tail 
manner to form two dimers (dimer A-B and C-D, Fig. 3a). Each monomer has two structurally 220 
distinct domains. The N-terminal domain, comprising residues 1-259, has an eight-stranded 
α/β-barrel fold, typical of phosphate-binding proteins. The C-terminal domain, residues 260-
391, contains mostly β-strands (Fig. 3b). 96% of the amino acids are in the preferred regions 
of the Ramachandran plot, 4% are in the allowed regions and no residues are in the 
unfavored areas. After refinement, the r.m.s. deviation between Cα’s of the two interacting 225 
molecules A and B is 0.0794 Å, and between C and D is 0.1431 Å. 
There are two active sites per dimer, which are located at the interface between each 
α/β-barrel of one subunit and the C-terminal domain of the other. The catalytic core (Fig. 4a) 
consists of the PLP cofactor, a Lys, and a Tyr, which is contributed by the other subunit. The 
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PLP is bound through an internal aldimine bond to the amino group of Lys46, located at the 230 
C-terminal side of the first β-strand of the α/β-barrel. The side chain of the catalytic Lys46 
points out of the α/β-barrel, towards the C-terminal domain of the interacting subunit, and in 
particular, towards Tyr283’. The phosphate group of the PLP is stabilized by hydrogen bonds 
with the side chains of Tyr50, Ser222 and Tyr374, and with the backbone of Gly239, Ser222 
and Ile240. The pyridine ring of the PLP is stabilized by a hydrogen bond between the N-1 of 235 
the cofactor and Nε of Arg237. The C2A of the PLP also interacts with oxygen Q1 of the 
carboxylated Lys141. All residues stabilizing the PLP cofactor (Tyr50, Ser222, Gly239, 
Ile240, Arg237, Tyr374) are conserved among Alr’s [32]. However, the AlrSco lacks one 
important hydrogen bond between Arg148 and the phenolic oxygen of the PLP molecule, as 
already observed for the AlrSla [34] [35]. Among the residues involved in PLP-stabilization, 240 
Tyr374, which corresponds to Tyr354 in the well-studied AlrGst, is particularly interesting. In 
fact, while always regarded as a PLP-stabilizer, Tyr354 was shown to be actually anchored 
by the hydrogen bond with the PLP so to ensure substrate specificity of the Alr [36]. 
 
Alr crystal structures bound to propionate and DCS 245 
The structure of AlrSco was solved in the presence of the two inhibitors propionate [37] and 
DCS  [11] to a resolution of 1.51 Å and 1.64 Å, respectively. In AlrSco, the carboxylic group of 
propionate binds in the same orientation in all four active sites present in the crystal unit. One 
of the carboxylic oxygens of propionate forms hydrogen bonds with the amino group of 
Met331’, the phenolic oxygen and CE2 of Tyr283’ and a water molecule, which bridges the 250 
substrate to several other water molecules in the active site. The second carboxylic oxygen 
of propionate interacts with N of Lys46, C4A of PLP, the phenolic oxygen of Tyr283’ and a 
water molecule. The electron density around C3 of propionate shows that this atom can have 
several orientations in the active site. In fact, it can either interact with O4 of the phosphate of 
PLP, the phenolic oxygen of Tyr283’ and a water molecule, or with the phenolic oxygen of 255 
Tyr50, the CE of Met331’, N of Lys46 and C4A of PLP (Fig. 4b). Both in AlrSco and AlrGst the 
hydrogen-bonding network stabilizing the propionate is very conserved. As argued by [37], 
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the propionate-bound form of the Alr can be considered a mimic of the Michaelis complex 
formed between the enzyme and its natural substrate L-Ala. 
DCS is an antibiotic produced by S. lavendulae and Streptomyces garyphalus, which 260 
covalently inhibits Alr [11, 38-42]. The structure of the AlrSco in complex with DCS shows that 
the amino group of the inhibitor replaces the Lys46 in forming a covalent bond with the PLP 
C4 (Fig. 4c). The nitrogen and oxygen atoms in the isoxazole ring form hydrogen bonds with 
Tyr302’, Met331’ and a water molecule. The hydroxyl group of the DCS ring also interacts 
with Met331’ and Arg148 (Fig. 4c). The catalytic Tyr283’ is at hydrogen-bond distance from 265 
the amino group of DCS. DCS molecules superpose well in three of the active sites of the 
crystal (A, B and C). However, the DCS-PMP adduct in the fourth site showed a shift of the 
DCS compared to the other sites, while PLP still superposed well. Comparison of the 
hydrogen bonds in the proximity of the active site in the free and in the DCS-bound form of 
Alr, revealed a role for Arg148 in substrate stabilization. In fact, while the side chain of 270 
Arg148 is hydrogen-bonded to Gln333 in free Alr, it shifted towards the hydroxyl moiety of 
the DCS upon binding of the inhibitor. Gln333 was stabilized by interaction with carboxylated 
Lys141. The rearrangement of the hydrogen bonds involving Arg148, Gln333 and Lys141 
does not occur in the propionate-bound structure, suggesting that Arg148 is involved in 
stabilization of the carboxylic group of the substrate. 275 
 
Alr and DCS resistance 
AlrSco shows high sequence and structural similarity to AlrSla. Based on crystallographic 
studies, AlrSla was proposed as one determinant of DCS resistance in the producer strain 
[11]. However, detailed structural comparison of different Alr proteins based on interatomic 280 
distances between active site residues, dimerization areas and hinge angles (see 
Supplementary Data), failed to establish a clear correlation between structural features and 
DCS resistance. It therefore remains unclear what the role of Alr is in DCS resistance in the 
producer strain. 
 285 
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In conclusion, our work shows that SCO4745 encodes the only Alr in S. coelicolor A3(2) and 
is essential for growth. Our structural studies on AlrSco and comparison to AlrSla suggest that 
there are more factors contributing to DCS resistance in bacteria, which relates well to recent 
studies on DCS-producing streptomycetes [43] and DCS-resistant strains of M. tuberculosis 
[44-47], . The availability of a S. coelicolor alr-null mutant and the crystal structure of the Alr 290 
from the same bacterium offer a new, valuable model for the study of DCS resistanc
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Table 1. Kinetic parameters for the racemization of L- and D-Ala by the recombinant 
Alr.  
The Michaelis-Menten constant (Km), maximum reaction rate (Vmax) and catalytic constant 
(kcat) of the Alr from S. coelicolor (AlrSco) are compared to the reported Km, Vmax and kcat of the 
Alr’s from S. lavendulae (AlrSla) and G. stearothermophilus (AlrGst). 
 L  D D  L 
 Km (mM) Vmax (U mg
-1) kcat (s
-1) Km (mM) Vmax (U mg
-1) kcat (s
-1) 
AlrSco 6.3  0.1 66.3  3.3 47.92.4 8.9  0.3 104.1  7.8 75.2  5.4 
AlrSla
‡ 
0.4  0.1 78.6  4.8‡‡ 55  3.3 0.4  0.2 90.5  9.5‡‡ 63.3  6.7 
AlrGst 5.1  0.6
* 2550
** 1533.3  50* 2.8  0.4* 1400
** 1016.7  33* 
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Table 2. Data-collection and refinement statistics 
 Free Alr DCS-bound Alr Propionate-bound Alr 
Space group P 1 21 1 P 1 21 1 P 1 21 1 
Unit-cell parameters 
a, b, c, α, β, γ 
78.96, 87.17, 109.63 
90.00, 102.26, 90.00 
79.74, 88.71, 109.14 
90.00, 102.25, 90.00 
79.95, 88.58, 108.88 
90.00, 102.60, 90.00 
Number of 
observations 
116287 480032 532661 
Number of unique 
reflections 
34569 177142 224510 
Completeness (%) 96.0 77.3 96.6 
Rpim (%), CC(1/2) 
highest resolution bin 
0.050, 0.991 0.037, 0.997 0.071, 0.985 
I/(I) 1.72 1.38 1.28 
Multiplicity 3.4 2.7 2.4 
Resolution range (Å) 107.12, 47.78-2.8 106.60(depositor), 
49.14(EDS)-1.64 
106.26, 48.06-1.51 
R factor (%) 21.3 21.6 21.2 
Rfree (%) 26.2 24.5 23.7 
R.m.s. deviations    
Bond lengths (Å) 0.62 0.88 0.98 
Bond angles () 0.84 0.96 1.05 
Number of atoms    
Protein (Chains A, B, 
C, D) 
2857, 2833, 2838, 
2833 
2922, 2851, 2846, 
2843 
3047, 2911, 2909, 
2926 
PLP 15 22 15 
Water 171 760 804 
Ramachandran plot    
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Preferred regions 96 97 97 
Allowed regions 4 3 3 
Outliers 0 0 0 
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Figure 1.  SCO4547 encodes alanine racemase Alr. 
(A) The alr null mutant of S. coelicolor requires supplemented D-Ala for growth. This 
phenotype is rescued by the introduction of plasmid pGWS1151, which expresses Alr. 
Strains were grown for 5 days on SFM agar plates. (B) Rescue of the S. coelicolor alr null 
mutant with D-Ala produced in vitro by Alr. Alr (0.2 nM) was incubated with 10 mM L-Ala for 
10 sec or 1, 5, 15, 30 or 60 min, followed by heat inactivation. The reaction mixture was then 
added to MM agar in 24-well plates and growth of the alr null mutant assessed. As a control, 
the same experiment was done with heat inactivated Alr (Alr*). Note the restoration of growth 
to the alr mutant after addition of the reaction mixture with active Alr, but not with heat-
inactivated Alr. The bottom rows show control experiments with added D-Ala or L-Ala 
(ranging between 0-1 mM). 
 
Figure 2. Multiple aminoacid sequence alignment of the Alr’s from S. coelicolor  (Sco), S. 
lavendulae (Sla; PDB 1VFT) and G. stearothermophilus (Gst; PDB 1XQK). The sequence 
alignment showing structural elements of AlrSco was generated with ESPript3.0. α-helices are 
shown as large coils labeled α, 310-helices are shown as small coils labeled η, β-strands are 
shown as arrows labeled β and β-turns are labeled TT. Identical residues are shown on a red 
background, conserved residues are shown in red and conserved regions are shown in 
boxes. 
 
Figure 3. Ribbon representation of the Alr from S. coelicolor. (A) The asymmetric unit 
contains two homo-dimers. The two chains within one dimer are colored in gold and dark 
cyan. (B) The N-terminal domain (1-259) is a α/β-barrel. The C-terminal domain (260-391) 
mostly comprises β-strands. The catalytic Tyr283 is highlighted in red. 
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Figure 4. Active site of the Alr without ligands (A) and in complex with propionate (B) and D-
cycloserine (C). The electron density 2F0-Fc map is shown for the PLP and the two inhibitors. 
The residues in the active site which are contributed from the monomer not bound to the PLP 
are indicated as primed numbers. Dotted lines indicate interatomic distances shorter than 
3 Å. 
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